October 2022 • PharmaTimes Magazine • 4-5

Contents

Features

Is our industry really opening doors for women?

Stem cell transplants have been changing lives for 65 years

Redefining how neurological conditions are understood

An essential clinical trial strategy for making 'local' mean more

Getting closer to the patient – pharma's reputation post-COVID

Analysis

UK healthcare and the NHS is on the cusp of an integral change

Pharma's role in taking on the health gap has rarely been so pivotal

Oli Hudson grapples with the role of ‘place’ in the new ICS landscape

How laboratories can truly reduce carbon emissions

Elevating the voices of rare disease patients in the modern age

SmartPeople

20.
Staying ahead of the game
Collected Group’s leadership team on navigating modern medical affairs

21.
Treatable blisters?
From blister packs to syringes, plastic is inseparable from pharma

22.
Seven up
A framework to support digital marketing strategies across pharma

28.
Access all areas
Market access challenges in a world of rare diseases

34.
Your moves
Where you're going and what you're doing there